human embryonic stem cells, human induced pluripotent stem cells, pluripotency, characterization
Ask a Question View Website
  • Research Group Leader
  • Stem Cells CSIRO Materials Science & Engineering

Research interests

Andrew and his team joined CSIRO Materials Science and Engineering in August 2009. Prior to this he was a Senior Scientist and Group Leader of the Human Embryonic Stem Cell Technology Laboratory at the Australian Stem Cell Centre. Dr Laslett’s research compares human embryonic stem cells to human induced pluripotent stem cells and is focused on exploiting the basic biology of these cell types to create novel tools that enhance pluripotent cell research translation. He leads an independent program as well as having significant national and international collaborations

Publications

  1. Laslett AL, Filipczyk A & Pera MF (2003). Characterization and Culture of Human Embryonic Stem Cells. Trends In Cardiovascular Medicine 13(7):295-301. Impact factor 4.367
  2. Martin F. Pera, Adam Filipczyk, Susan M. Hawes, and Andrew L. Laslett (2003) Isolation, characterization, and differentiation of human embryonic stem cells. Methods in Enzymology 365: 429-46. Impact factor 1.904
  3. Herszfeld D, Wolvetang E, Filipczyk A, Langton –Bunker E, Koh K, Nguyen L, Tellis I, Michalska A, Laslett AL, Reubinoff BE, Houssami S, Looijenga LH and Pera MF (2006) CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nature Biotechnology 24(3):351-7.  Impact factor 29.495 
  4. Laslett AL, Grimmond S, Gardiner B, Stamp L, Lin A, Hawes S, Wormald S, Nikolic-Paterson D, Haylock D and Pera MF (2007)  Transcriptional Analysis of Early Lineage Commitment In Human Embryonic Stem Cells.  BMC Developmental Biology Mar 2;7:12. Impact factor 3.290
  5. Filipczyk AA, Laslett AL, Mummery C & Pera MF (2007) Differentiation is Coupled to Changes in the Cell Cycle Regulatory Apparatus of Human Embryonic Stem Cells. Stem Cell Research 1:1; 45-60. Impact factor 3.368
  6. Gubhaju L, Laslett A, Bertram JF, Zulli A, Black JM (2008) Immunohistochemical localisation of TRA-1-60, TRA-1-81, GCTM-2 and podocalyxin in the developing baboon kidney. Histochemistry and Cell Biology 129(5):651-7. Impact factor 3.021 
  7. Kolle G, Ho SHM, Zhou Q, Chy HS, Krishnan K, Cloonan N, Bertoncello I, Laslett AL and Grimmond SM (2009) Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling. Stem Cells 27:2446–2456. Impact factor 7.871
  8. Shelley R. Hough, Andrew L. Laslett, Sean Grimmond, Gabriel Kolle, and Martin F. Pera. (2009) A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells.  PLoS One.  2009 Nov 5;4(11):e7708. Impact factor 4.351
  9. Louise C Laurent, Caroline M Nievergelt, Candace Lynch, Eyitayo Fakunle, Julie Harness, Uli Schmidt, Vasiliy Galat, Andrew L Laslett, Timo Otonkoski, Hans Keirstead, Andrew Schork, Hyun-Sook Park & Jeanne F Loring (2010) Restricted ethnic diversity in human embryonic stem cells. Nature Methods 7(1):6-7. Impact factor 16.874 
  10. S. Adelia Lin, Gabriel Kolle, Sean Grimmond, Qi Zhou, Elizabeth Doust, Melissa H. Little, Bruce Aronow, Sharon D. Ricardo, Martin F. Pera, John F. Bertram and Andrew L. Laslett. (2010) Subfractionation of differentiating hES cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells and Development October 2010, 19(10): 1637-1648. Impact factor 4.791
  11. Louise C. Laurent, Igor Ulitsky, Ileana Slavin, Ha Tran, Andrew Schork, Robert Morey, Candace Lynch, Julie Harness, Sunray Lee, Maria J. Barrero, Marina Martynova, Franz-Josef Muller, Ruslan Semechkin, Vasiliy Galat, Joel Gottesfeld, Juan Carlos Izpisua Belmonte, Chuck Murry, Hans Keirstead, Hyun-Sook Park, Ulrich Schmidt, Andrew L. Laslett, Caroline M. Nievergelt, Ron Shamir, Jeanne F. Loring (2011). Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ES and iPS Cells during Reprogramming and Time in Culture. Cell Stem Cell 8(1):106-18. Impact factor 25.943.
  12. Naohisa Wada*, Bei Wang*, Ni-Hung Li, Andrew L. Laslett, Stan Gronthos, P. Mark Bartold. (2011) Establishment of induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament stem cells. Journal of Periodontal Research 46: 438–447 Impact factor 2.128* co-first authors12. 
  13. Bi Song, Samy Sakkal, Maliha A. Alikhan, Peter G. Kerr, Andrew L. Laslett, Claude A. Bernard and Sharon D. Ricardo (2011). Generation of induced pluripotent stem cells from human kidney mesangial cells. Journal of the American Society for Nephrology 22:1213-1220 Impact factor 8.288 
  14. Kolle G, Shepherd J, Gardiner B, Kassahn K, Cloonan N, Nourbakhsh E, Taylor DF, Wani S, Chy HS, Zhou, Q, McKernan K,  Kuersten S, Laslett AL, Grimmond, SM. (2011) Deep-transcriptome and ribonome sequencing redefines the molecular networks of pluripotency and the extracellular space in human embryonic stem cells. Genome Research 21(12):2014-25. Impact factor 13.588
  15. Raymond Ching-Bong Wong, Sara Pollan, Helen Fong, Abel Ibrahim, Ellen Smith, Mirabelle Ho, Andrew L. Laslett, Peter Donovan. Novel role of a RNA polymerase III subunit POLR3G in regulating pluripotency in human embryonic stem cells. Stem Cells 29 (10):1517-27. Impact factor 7.871
  16. The International Stem Cell Initiative: Katherine Amps, Peter W Andrews, George Anyfantis, Lyle Armstrong, Stuart Avery, Hossein Baharvand, Julie Baker, Duncan Baker, Maria Barbadillo Munoz, Stephen Beil, Nissim Benvenisty, Dalit Ben-Yosef, Juan-Carlos Biancotti, Alexis Bosman, Romulo Martin Brena, Daniel Brison, Gunilla Caisander, María Vicenta Camarasa, Jieming Chen Eric Chiao, Young Min Choi, Andre B H Choo, Daniel Collins, Alan Colman, Jeremy Micah Crook, George Q Daley, Anne Dalton, Paul A De Sousa, Chris Denning Janet Downie, Petr Dvorak, Karen Dyer Montgomery, Anis Feki, Angela Ford, Victoria Fox, Ana M Fraga, Tzvia Frumkin, Amparo Galán, Lin Ge, Paul J Gokhale, Tamar Golan-Lev, Hamid Gourabi, Michal Gropp, Lu Guangxiu, Ales Hampl, Katie Harron, Lyn Healy, Wishva Herath, Frida Holm, Outi Hovatta, Johan Hyllner, Maneesha S Inamdar, Astrid Kresentia Irwanto, Tetsuya Ishii, Marisa Jaconi, Ying Jin, Susan Kimber, Sergey Kiselev, Barbara B Knowles, Oded Kopper, Valeri Kukharenko, Anver Kuliev, Maria A Lagarkova, Peter W Laird, Majlinda Lako, Andrew L. Laslett, Neta Lavon, Dong Ryul Lee, Jeoung Eun Lee, Chunliang Li, Linda S Lim, Tenneille E Ludwig, Yu Ma, Edna Maltby, Ileana Mateizel, Yoav Mayshar, Maria Mileikovsky, Stephen L Minger, Takamichi Miyazaki, Shin Yong Moon, Harry Moore, Christine Mummery, Andras Nagy, Norio Nakatsuji, Kavita Narwani, Steve K W Oh, Sun Kyung Oh, Cia Olson, Timo Otonkoski, Fei Pan In-Hyun Park, Steve Pells, Martin Pera, Lygia V Pereira, Ouyang Qi, Grace Selva Raj, Benjamin Reubinoff, Alan Robins, Paul Robson, Janet Rossant, Ghasem H Salekdeh, Eva Sánchez, Thomas C Schulz, Karen Sermon, Jameelah Sheik Mohamed, Hui Shen, Eric Sherrer, Kuldip Sidhu, Carlos Simon Vallés, Shirani Sivarajah, Heli Skottman, Claudia Spits, Glyn Stacey, Raimund Strehl, Nick Strelchenko, Hirofumi Suemori, Bowen Sun, Riitta Suuronen, Kazutoshi Takahashi, Timo Tuuri, Parvathy Venu, Yuri Verlinsky, Dorien Ward-van Oostwaard, Daniel J Weisenberger, Yue Wu, Shinya Yamanaka, Lorraine Young & Qi Zhou. (2011) Screening a large, ethnically diverse population of human embryonic stem cells identifies a chromosome 20 minimal amplicon that confers a growth advantage. Nature Biotechnology 29(12):1132-44. Impact factor 31.090
  17. Kristopher L. Nazor, Gulsah Altun, Candace Lynch, Ha Tran, Julie V. Harness, Ileana Slavin, Ibon Garitaonandia, Franz Joseph Müller, Yu-Chieh Wang, Francesca S. Boscolo, Eyitayo Fakunle, Sunray Lee, Hyun Sook Park, Marina Martynova, Tsaiwei Ole, Darryl D.D'Lima, Ruslan Semechkin, Mana M. Parast, Vasiliy Galat, Andrew L. Laslett, Uli Schmidt, Hans S. Keirstead, Jeanne F. Loring, Louise C. Laurent (2012). Recurrent Variations in DNA Methylation in Human Pluripotent Stem Cells and their Differentiated Derivatives. Cell Stem Cell 10, 620–634 Impact factor 25.943

Go to top